Area of research
Infectious Diseases · Computer Science Applications
Research interest
Research interests include Dolutegravir, Pharmacology, Gut flora, Biology, Hepatocellular carcinoma, and Gene silencing.
Silencing PTPN2 with nanoparticle-delivered small interfering RNA remodels tumor microenvironment to sensitize immunotherapy in hepatocellular carcinoma
Comparison of Efavirenz and Dolutegravir on Gut Microbiome and Gut Barrier Functions
Indirubin regulates M1/M2 polarization and inhibits ferroptosis in dextran sulfate sodium induced colitis and in cultured THP-1 cells
Alteration in Gut Microbiome and Intestinal Barrier Function caused by Efavirenz versus Dolutegravir Treatments in Mice
Clinical characteristics of 100 cases of coronavirus disease 2019 in Dongguan, China